Skip to main content

Table 4 Case Management

From: Ophthalmic emergency-room visits during the Covid-19 pandemic – a comparative study

Variable

March–April

2019

March–April

2020

P Value

Treatment

n (%)

 No treatment

244 (29.2%)

104 (23.2%)

p = 0.003

 Topical antibiotics

331 (39.7%)

227 (47.6%)

p = 0.005

 Topical steroids

88 (10.5%)

97 (20.3%)

p < 0.001

 Lubrication

187 (22.2%)

143 (30%)

p = 0.003

 Systemic antibiotics

47 (5.6%)

22 (4.6%)

p = 0.425

 Systemic steroids

4 (0.47%)

10 (2.1%)

p = 0.01

 Intravitreal injections

19 (2.3%)

12 (2.5%)

p = 0.851

 Glaucoma treatment (Topical and systemic)

14 (1.7%)

28 (5.9%)

p < 0.001

 Othera

12 (1.4%)

41 (8.6%)

p < 0.001

Number of treatments

mean (SD)

0.84 (0.67)

1.22 (0.95)

p < 0.001

One treatment

n (%)

493 (59.1%)

221 (46.3%)

p < 0.001

Two or more treatments

n (%)

97 (11.6%)

151 (31.6%)

p < 0.001

Auxiliary tests

n (%)

 No Auxiliary tests

751 (90%)

388 (81.3%)

p < 0.001

 OCT

64 (7.7%)

62 (12.3%)

p = 0.002

 Visual fields

20 (2.4%)

16 (3.3%)

p = 0.38

 FA

6 (0.7%)

13 (2.7%)

p = 0.006

 US

8 (0.9%)

14 (2.9%)

p = 0.012

Number of Auxiliary tests

mean (SD)

1.02 (0.16)

1.06 (0.3)

p < 0.001

Office procedures

n (%)

 No office procedures

673 (80.7%)

368 (77.1%)

p = 0.127

 Foreign body removal cornea

63 (7.5%)

58 (12.2%)

p = 0.008

 Foreign body removal conjunctiva

47 (5.6%)

17 (3.6%)

p = 0.094

 Laser Barrage

22 (2.6%)

15 (3.1%)

p = 0.594

 Eye irrigation

19 (2.3%)

6 (1.2%)

p = 0.311

Hospitalizations

n (%)

28 (3.3%)b

9 (1.9%)c

p = 0.165

Follow up location

n (%)

 Hospital

254 (30.4%)

222 (46.5%)

p < 0.001

 Outside clinic

403 (48.3%)

169 (35.4%)

p < 0.001

 None

177 (21.2%)

85 (17.8%)

p = 0.154

Number of emergent surgeries

15 (1.8%)

17 (3.7%)

p = 0.046

Time from diagnosis to surgery, days

mean (SD)

2.86 (1.91)

2.23 (1.95)

p = 0.364

Number of in hospital consults

16 (1.9%)

14 (2.9%)

p = 0.236

  1. Abbreviations: OCT optical coherence tomography, FA fluorescein angiography, US ultrasound, SD standard deviation
  2. aAcyclovir; Anti-allergic treatment (topical and systemic)
  3. b 3rd nerve palsy, optic neuritis (ON) and anisocoria in neurologic department (3), corneal abscess (1), peri-orbital cellulitis (3), high IOP (5), ruptured globe and conjunctival laceration (2), endophthalmitis following anti- VEGF injection, retinal artery occlusion (RAO) and vein occlusion for systemic evaluation (3), evisceration (1), retinal detachment (RD) (3) and thyroid eye disease for systemic steroids (1)
  4. cRAO (1), retinitis (1), RD (1), ON (4), high IOP and VZV with corneal involvement